Shared Decision-Making and Future Directions in Sjogren’s Disease

In this concluding episode, the panel reflects on the importance of shared decision-making as the treatment landscape for Sjögren’s Disease (SjD) continues to evolve. They emphasize that effective care requires open dialogue about symptoms, treatment goals, and the patient’s daily experience, particularly because fatigue, pain, and dryness affect individuals differently. The panel encourages clinicians to validate patient concerns, avoid minimizing symptoms, and consider the emotional and functional impacts of the disease.

Looking ahead, the group is optimistic about the future, with emerging mechanisms of action, improved biomarkers, and more targeted therapies offering renewed hope for disease-modifying treatment. They highlight the need for ongoing patient education, interdisciplinary collaboration, and continued research to refine patient selection and optimize clinical outcomes. The segment closes with a message of empowerment: patients and clinicians are partners, and together they can navigate complex choices and move toward more personalized and meaningful care in SjD.